Diagonal’s DIAG723 Antibody Gets ODD from U.S. FDA and EMA
18 Jun 2025 //
GLOBENEWSWIRE
Diagonal Therapeutics to Present Disease-Modifying Data at EHA
12 Jun 2025 //
GLOBENEWSWIRE
Diagonal Starts Study On HHT, A Rare Bleeding Disorder
04 Mar 2025 //
GLOBENEWSWIRE
Diagonal Therapeutics Presents HHT Burden Data at ASH 2024
03 Dec 2024 //
GLOBENEWSWIRE